Daily Alpha · Reddit
· Premarket Alpha · by Buzzberg Research
Reddit posts weighed Flex against Celestica, a Sandisk short and Tempus AI's profitability, while r/wallstreetbets split between Nvidia buyers and put holders.
Themes on this desk
Nvidia buyers versus put holders
In r/wallstreetbets, commenters disclosed buying or adding to Nvidia, while others held puts, including a 69-put, $115K post citing Megaspeed export-control risk.
Highest engagement
by score · day changeA r/ValueInvesting post argues Flex is underappreciated versus Celestica at a similar market cap
The author cites Flex's $31B revenue against Celestica's $18B, more end-market diversification, cloud and power momentum with expanding margins, and a planned spin-off of its higher-growth segment.
FLEX: $31B revenue vs Celestica’s $18B, similar market caps:
The post frames Flex as an underappreciated AI infrastructure play.
Watch The planned spin-off of Flex's higher-growth segment.
Source →A r/wallstreetbets poster reports shorting Sandisk from 1800 to 850
The author argues cyclical tops rhyme and this one was no different, after being mocked for suggesting SNDK would drop below 1000 again.
WSB called me regarded for suggesting SNDK would ever drop below 1000 again.Source →
Tempus AI posted $26M of Q3 adjusted EBITDA but a $57M operating loss, a r/StockMarket post notes
The author highlights negative free cash flow and high stock-based compensation despite positive adjusted EBITDA, and plans to revisit forward forecasts at full-year results.
Tempus AI (TEM) after Q3: $26M adjusted EBITDA, a $57M operating loss. What counts as profitable?
The post questions what counts as profitable for Tempus AI.
Watch Tempus AI's full-year results.
Source →A Capricor holder points to more positive HOPE-3 cardiac data 13 days before the FDA decision
The author holds CAPR shares and sees the positive HOPE-3 cardiac data plus high short interest as an increasingly interesting setup ahead of the November 22 PDUFA decision.
$CAPR More Positive HOPE-3 Cardiac Data Just 13 Days Before FDA Decision Capricor announced additional positive cardiac findings from its
Watch The November 22 PDUFA decision.
Source →A r/AMD_Stock post calls AMD's 13% rally an unconfirmed reversal
The author reviews strong results and guidance but says the reversal is unconfirmed, watching $523 and $548 as confirmation levels and $468 as the level that would undercut the case.
AMD Up 13% Today. Is This a Real Reversal or Just a Dead Cat Bounce?
Watch $523 and $548 for confirmation; a fall below $468 would undercut the case.
Source →Most argued
by comments per upvoteA financial advisor scored 16 AI stocks on capex-slowdown resilience, ranking Alphabet, TSMC and Microsoft highest
The scores weigh profitability, debt, customer diversification, pricing power, valuation and capex-slowdown resilience, with Oracle, Nebius and CoreWeave ranked lowest.
AI bubble or not, there will be winners and losers.Source →
SOXL reportedly drew $2.2 billion the day after a 38% drop, a r/ETFs post notes
The author questions whether holders treat the leveraged semiconductor ETF as a long-term or short-term position after the large single-day inflow.
SOXL dropped 38% during last week's selloff, then investors poured $2.2 billion into it the next day I found thisSource →
A r/ValueInvesting post pitches Dundee Corp at a 43% discount to NAV
The long thesis rests on cash and mining stakes plus an earn-in of up to C$85M into Westhaven's Shovelnose gold project.
Dundee Corp (TSX: DC.A): a holding company at a 43% discount to NAV that is spending C$85M to transform intoSource →